EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG)

Autoantibodies, Endomysial(tissue Transglutaminase)

Euroimmun US, Inc.

The following data is part of a premarket notification filed by Euroimmun Us, Inc. with the FDA for Euroimmun Anti-tissue Transglutaminase Elisa (iga), Euroimmun Anti-tissue Transglutaminase Elisa (igg).

Pre-market Notification Details

Device IDK183313
510k NumberK183313
Device Name:EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG)
ClassificationAutoantibodies, Endomysial(tissue Transglutaminase)
Applicant Euroimmun US, Inc. 1 Bloomfield Avenue Mountain Lakes,  NJ  07046
ContactDaniel Castellanos
CorrespondentDaniel Castellanos
Euroimmun US, Inc. 1 Bloomfield Avenue Mountain Lakes,  NJ  07046
Product CodeMVM  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2018-11-29
Decision Date2019-02-28

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
04049016027294 K183313 000
04049016027287 K183313 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.